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 Introduction
Epilepsy has a 120/100000 incidence ratio in the first year of life and an incidence 
ratio of 40–50/100000 in 1- to 10-year-old children (1). This disease is the most 
common reason for referral to neurology clinics. A total of 15–20% of the epileptic 
cases is resistant to drug therapy (2).
Refractory epilepsy is one of the true nuisances in child neurology that causes 
increasing annual costs for treatment (3).
There is no agreed upon definition of refractory epilepsy among the authorities. 
Many physicians believe that refractory epilepsy applies to the type of epilepsy that 
is not controlled with three to four appropriate medications with an acceptable dosage 
and proper duration (3). Persistent attacks may lead to irrevocable complications 
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Intractable epilepsy is a major difficulty in child neurology, because the numbers 
of drugs that are available for treatment are limited and new treatments such as 
diets must be tried. Now there are some diets available for treating patients with 
intractable epilepsy. The oldest diet is the classic ketogenic diet and one of the 
newest diets is the modified Atkins diet. Patients have a harder time accepting 
the classic ketogenic diet than the Atkins diet, which is easier to accept because 
the food tastes better. This study compares the efficacy of the ketogenic diet and 
the Atkins diet for intractable epilepsy in children.
Materials & Methods 
This study is a clinical trial survey with sample size of 40 children with refractory 
epilepsy who were patients at Mofid hospital in Tehran, Iran. Initially, from Jan 
2005–Oct 2007, 20 children were treated with the Atkins diet, and then from Oct 
2007–March 2010, the other group was treated with the classic ketogenic diet 
and the results were compared.
Results
In this study, response to treatment was greater than a 50% reduction in seizures 
and at the end of first, second, and third months for the ketogenic diet were 55%, 
30%, and 70% and for the Atkins diet were 50%, 65%, and 70%, respectively.
Conclusion 
The results of this study show that there is no significant difference between the 
classic Ketogenic diet and the Atkins diet at the end of first, second, and third 
months and both had similar responses to the treatments.
Keywords: Classic ketogenic diet; Atkins diet; Intractable epilepsy.
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to the brain. Currently, the treatment methods for this 
problem such as surgery, vagus nerve stimulation, new 
medications, and the Ketogenic diet are costly except for 
the Ketogenic diet. The Ketogenic diet has been applied 
in neurology for at least90 years. In 1910, Gopa and Marie 
published a report concerning the impact of fasting as a 
treatment for epilepsy, but since fasting was impractical, 
it was largely forgotten. In 1972, Livingstone of the John 
Hopkins Center cured approximately 1000 epileptic 
patients with the Ketogenic diet and later, Freeman 
(from Johns Hopkins as well) continued Livingstone’s 
work. Today the Ketogenic diet is a standard treatment 
for refractory epilepsy (4–7). In the Ketogenic diet, 
the daily calorie intake is reduced by75% and 1gm/kg 
protein and 5–10 gm carbohydrate is recommended with 
the remainder of daily calorie intake provided by fat (4). 
Researchers have suggested some alteration to the diet 
to make it more practical and acceptable for children. 
The Atkins diet is the diet of last resort. This diet was 
introduced by Robert Atkins in 1970 for the prevention 
of obesity. In this diet, just as in the Ketogenic diet, 
carbohydrates are restricted and fat is increased to result 
in weight loss. If the amount of carbohydrates restricted 
is sufficient to cause ketosis in patients, then it may lead 
to a decrease of epileptic attacks in refractory epileptic 
children (4).
In the Atkins diet, severe restrictions on daily calorie 
consumption and protein are unnecessary. We intend 
to evaluate the effects of the classic Ketogenic diet and 
Atkins diet on children with refractory epilepsy and 
compare the decreases in epileptic attacks.
Materials & Methods 
Definitions
Refractory Epilepsy: Epilepsies that are not cured 
by at least three first line anti-epileptic medications 
(barbiturates, benzodiazepines, phenytoin, 
carbamazepine, sodium valproate, and/or ethusuximide) 
with accurate indications, appropriate dosages, and 
sufficient durations (3).
Atkins Diet: A diet that suggests 60% of the necessary 
daily calorie intake is provided by fat, 30% by protein, 
and limited to 10 gm of carbohydrates (4).
Ketogenic Diet: A diet that suggests the daily calorie 
intake is reduced by75%. The daily calorie intake 
is provided by 1 gm/kg of protein and 5–10 gm of 
carbohydrates and the remainder of the calorie intake is 
provided by fat (4).
Response to treatment: Reductions of greater than 50% 
in the number of daily epileptic attacks after starting the 
diets.
Enrolled Criteria
All 1- to 16-year-old patients who suffered from 
refractory epilepsy within the criteria listed below:
1. No febrile convulsions;
2. Without brain neoplasm and progressive 
neurologic diseases; and,
3. Children of mothers with at least primary school 
education.
In this study, from January 2005–October 2007, 20 
patients aged1 to 16 years of age with refractory epilepsy 
who were referred to the neurology clinic of Mofid 
hospital in Tehran, Iran and met the above criteria for the 
study were treated with the Atkins diet. Alternatively, 
from October 2007–March 2010, another 20 patients 
aged 1 to 16 years of age who were similar to the first 
group of patients for age and frequency of attacks 
were put on the Ketogenic diet. First, the demographic 
data, parent education and job, the type and number of 
epileptic attacks, positive clinical manifestations, EEG 
and neuroimaging, anti-epileptic drugs, and the duration 
of previous treatments were entered on the evaluation 
forms. The results of the treatment were recorded after 
the first, second, and third months.
Statistical Analysis
After the data was gathered, a statistical analysis was 
performed using paired t-test, the Fisher’s exact test, 
Friedman’s non-parametric, Wilcoxon’s non-parametric 
test, and repeated measure analysis of variance 
(ANOVA). SPSS 17 for Windows (SPSS Inc., Chicago, 
IL) was used for statistical analysis. This study was 
approved by the ethics committee of Shahid Beheshti 
University of Medical Sciences. Informed consent was 
given by the parents of patients in this study.
Results
Tables 1–5 show the demographic data and the 
frequency of the variables in both groups. The mean of 
daily seizures before the Atkin’s diet was 14.15±12.60 
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(range, 2–50) and for the Ketogenic diet was 
15.30±14.67 (range, 2-50). There were no significant 
differences evident between the mean number of daily 
attacks before treatment (p=0.862) and shows that they 
were similar in the number of attacks when the data 
was compared.
In the Atkin’s diet group after 1-month, 2-months, and 
3-months of the diet, a mean value of 7.6±11.47 (range, 
0–50), 6.75±11.11 (range, 0–50), and 6.60±11.25 (range, 
0–50) daily seizures were reported, respectively. These 
values were 6.50±8.29 (range, 0–30), 3.20±4.94 (range, 
0–20), and 7.5±11.75 (range, 0–35), respectively, for 
the Ketogenic diet group. We used the Kolmogorov-
Smirnov test in which none of the variables showed 
normal distribution (all four p-values<0.01)to compare 
the normal distribution of the seizures in each group. 
The Wilcoxon non-parametric test was used to compare 
the mean number of daily attacks before starting the 
Atkins and the Ketogenic diet with the number of 
seizures after 1-, 2-, and 3-months of treatment in 
each group to consider the non-normal distribution for 
the number of seizures at the different stages. In the 
Atkins group, after 1-month (p<0.001), after 2-months 
(p=0.001), and after 3-months (p=0.001) showed 
significant differences when compared to data from 
before the diet was started. In the Ketogenic group, 
after 1-month (p<0.001), after 2-months (p<0.001), 
and after 3-months (p=0.002) showed significant 
differences when compared to the data from before the 
diet was started. These results reveal that both diets are 
effective in lowering the number of attacks.
The response to treatment, which was a reduction of 
greater than 50% in the number of daily attacks when 
compared with data from before treatment; after 
1-month of diet treatment: in the Atkins group, 50% of 
patients and in the Ketogenic group, 55% of the patients 
showed improvements from the diet treatments.
After 2-months of diet treatment, the success rate 
was 65% for the Atkins diet group and 30% for the 
Ketogenic diet group; and after 3-months, 70% of the 
Atkins diet group, and 70% of the Ketogenic diet group 
had appropriate responses. Using the Fishers exact test 
to compare the two groups, a significant difference 
was not detected between the groups after 1-(p=1), 
2-(p=0.127), and 3-months (p=1) and both diets were 
similarly successful in response to treatment.
After 3-months of diet treatment, 30% of the patients 
in both groups, which showed reduction of greater than 
50% in the frequency of seizures when compared with 
the data from before the ; had no response to the diets. 
A total of 35% of the Atkins diet group and10% of the 
Ketogenic diet group had a 51–75% decrease in the 
frequency of seizures.
A 76–99% decrease was detected in 15% of the Atkins 
diet patients and 30% of the Ketogenic diet patients 
after 3-months of the therapy. In addition, 20% 
(4cases) of the Atkins group and 30% (6 cases) of the 
Ketogenic group indicated no seizures. The Chi-square 
test indicated that there was no significant difference 
between the two groups.
There was also no correlation between the age of 
patients at the start of diet, gender, parent education 
and job, type of seizures, type of epileptic syndrome, 
brain imaging findings, EEG findings, and decreases 
in the frequency of seizures after 3-months therapy in 
either of the diets.
The follow up duration for these patients for each group 
was 3-months due to limitations but many patients 
especially those patients who had a good response 
and continued the diet as well as all patients who did 
not respond well from anti-epileptic drugs and the 
adherence to the diets was good had positive parental 
response to the diet.
Discussion
Previous studies have indicated the effectiveness of the 
Ketogenic diet and to a lesser degree on the Atkins diet, 
the impact, and assessment separately on refractory 
epilepsy. Tonekaboni et al. in Iran (8) indicated that 
after 3-months on the Atkins diet, 66.7% of patients 
had greater than 50% and 25% had greater than 99% 
decreases in the frequency of seizures. Furthermore, 
20.8% of the patients were seizure-free.
Eric H. Kossoff indicated that the effectiveness of the 
Atkins diet (9) was45% of patients had 50–90% and 
28% of the patients had greater than 90% decreases in 
the number of seizures.
Susanne Weber et al. in Denmark indicated that the 
Atkins diet was used for treatment of 15 children with 
refractory epilepsy. After 3-months, six patients (40%) 
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had greater than a 50% reduction in the number of 
seizures. After 12-months, only three patients (20%) 
continued the diet with no significant change in the 
frequency of seizures.
Mirjavadi et al. showed that the effectiveness of the 
Ketogenic diet in 66 children in Iran (10) with11 patients 
not continuing the diet. After 3-months, 71% of the 
patients had greater than 50% fewer epileptic attacks. 
This study is reliable, because of the relevant sample size. 
Karimzadeh et al. study on 87 children with refractory 
seizure showed ketogenic diet caused50% reduction in 
seizure frequency in 87% of patients and 39% of whom 
showed complete seizure control in the third month (11).
Barzegar et al. (2009)at the Tabriz Children’s hospital, 
the impact of the Ketogenic diet was evaluated on 
28 1.5–14-year-old (mean, 6.8 years) children with 
refractory epilepsy who had no response to two anti-
epileptic drug medications (12). These patients had a 
mean number of 14 seizures a week and were followed 
up for 6-months. After 1-month of the diet, 42.9% of the 
children were seizure-free and 28.6% had a greater than 
50% decrease in seizure frequency. After 3-months on 
the diet, 39% were seizure free and 14% had at least a 
50% decrease in the frequency of seizures. These figures 
were 28.63% and 17.9%, respectively after 6-months 
on the diet. A39% decrease in the number of attacks 
demonstrates the positive effect of the diet as a treatment 
for refractory epilepsy.
 In our study, at the end of 3-months 70% of the patients 
in each group with a 50% reduction in the number of 
seizures showed an appropriate response to the diet.
The results of all mentioned studies that were done 
with the Ketogenic and Atkins diets separately and 
were similar to our study in that they showed a good 
response to these diets for the reduction in the frequency 
of seizures.
In a systematic assessment of 11 published articles 
performed by Naomi Aranson and Frank Lefevre (13) 
on the impact of the Ketogenic diet as shown below with 
the results indicated:
A total of 16% of patients were seizure-free, 32% of 
patients had greater than a 90% decrease, and 56% had 
greater than a 50% decrease in seizure frequency.
In another systematic review performed by Daniel 
L. Keene on the Ketogenic diet (14), 14 studies were 
evaluated and the results showed that 15.6% were 
seizure-free and 33% of the patients had greater than a 
50% decrease in the frequency of seizures.
The results of these two systematic reviews also support 
our study regarding the anti-epileptic effects of the diets 
as treatment.
In our study, a comparison of the two groups using the 
Fisher exact test did not indicate a significant difference 
regarding the effectiveness of the diets. Moreover, 30% 
of the patients in each group did not respond to treatment 
at all, 35% of the Atkins group and 10% of the Ketogenic 
group had approximately 51–75% seizure frequency 
reduction and in 15% of the patients on the Atkins diet 
and 30% of the patients on the Ketogenic diet showed an 
approximate76–99% seizure frequency reduction was 
observed. A total of 20% of the Atkins diet group and 
30% of the Ketogenic diet group were seizure-free after 
3-months. The Chi-square test showed no significant 
differences observed between the two groups.
Natach Porta et al. at the Lille University-affiliated 
Hospital, France (15) showed that these two diets when 
compared to a smaller sample size of 27 patients, of 
which 17 were on the Ketogenic diet and 10 were on the 
Atkins diet for 6-months; the response to treatment was 
65% for the Ketogenic diet and 20% for the Atkins diet 
after 3-months.This indicates a significant difference 
between the two groups and shows that the Ketogenic 
diet was more successful. However, after 6-months 41% 
of the Ketogenic diet group and 20% of the Atkins diet 
group exhibited responses to their respective diets that 
demonstrated no significant differences on the anti-
epileptic effects.
Similar to our study, our results were similar after 
6-months and showed that the same effect from the two 
diets, but the results were different after 3-months.
We think two reasons that explain these differences are 
as follows: 1.the smaller number of patients in Porta et 
al (15), and 2.different causes of refractory epilepsy in 
these two studies.
In conclusion, based upon the aforementioned studies, 
the effectiveness of the Atkins and Ketogenic diets 
on refractory epilepsy has been defined and we have 
concluded equal effects from both diets. Since, the 
Atkins diet is easier to implement and maintain when 
compared to the Ketogenic diet, i.e., there is no need 
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for hospitalization, no restriction of protein, calories, 
fluids as well as better tasting food, it may be possible 
to replace the Ketogenic diet with the Atkins diet for the 
treatment of refractory epilepsy.
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Table 1. The Mean Age and Gender Distribution in the Atkins and Ketogenic Diet Groups
Variables Atkins Ketogenic P-Value





Table 2. Fathers’ Job from the Study Groups
Variables Tradesman Laborer Employee P-Value
Fathers’ Job
Atkins 50%(10) 5%(1) 45%(9)
0.312
Ketogenic 35(7)% 20(4)% 45(9)%
Table 3. Mothers’ Job in the Study Groups









Up to Licentiate Beyond Licentiate P-Value
Fathers’ 
Education
Atkins 70%(14) 25%(5) 5%(1)
1.000
Ketogenic 70%(14) 25%(5) 5%(1)
Mothers’ 
Education
Atkins 70%(14) 3%(6) 0%(0) 0.344
Ketogenic 80%(16) 15%(3) 5%(1)
The Ketogenic and Atkins Diets Effect on Intractable Epilepsy: A Comparison
17Iran J Child Neurol. 2014 Summer Vol 8 No 3 
References
1. Camfield CS, Canfield PR, Gordon K, Wirrell E, Dooley 
JM. Incidence of epilepsy in childhood and adolescents in 
Nova Scotia. Epilepsia, 1996 Jan;37(1):19-23.
2. Gessner U, Sagmeister M, Horisberger B. The cost of 
Epilepsy in Switzerland. Int J Health Sci 1993;4:121-8.
3. Aicardi J. Epilepsy in children. Philadelphia: Lippincott 
epilepsy. Lancet Neurol 2004 Jul;3(7):415-20.
5. Hassan AM, Keene DL, Whiting SE, Jacob PJ, Champagne 
JR, Humphreys P. Ketogenic diet in the treatment of 
refractory epilepsy in childhood. Pediatr. Neurol. 1999; 
21: 548-552.
6. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, 
Camfield PR, Holmes GL et al. A multicenter study of 
the efficacy of the ketogenic diet. Arch Neurol 1998 
Nov;55(11):1433-7.
7. Nordli DR, Kuroda MM. Experience with the ketogen diet 
in infants. Pediatrics 2001 Jun; 108(1):129-33.
8. Tonekaboni SH, Mostaghimi P, Mirmiran P, Abbaskhanian 
A, Abdollah GF, Ghofrani M, et al. Efficacy of Atkins 
diet as therapy for intractable epilepsy in children. Arch 
Iran Med 2010 Nov;13(6):492-7.
9. Kossoff EH, Dorward JL. The modified Atkins diet. 
Epilepsia 2008 Nov;49 Suppl 8:37-41. 
10. Mirjavadi SAR, Tonekaboni SH, Ghazavi MR, Azarghashb 
E, Abdollah GF, Ghofrani M. Efficacy of ketogenic diet 
as a therapy for intractable epilepsy in children. Iran J 
Child Neurol 2010 Sep;4(2):27-36.
11. Karimzadeh P, Tabarestani S, Mahvelati F, Tonekaboni 
SH, Ghofrani M. Intractable seizure disorfes; efficacy of 
the classic ketogenic diet. Iran J Child Neurol 2009 Jan; 
3(1):15-20.
12. Barzegar M, Ostad Rahimi AR, Eslampour Sh, Shabazi 
Sh. The Ketogenic diet for refractory epilepsy. Med J 
Tabriz Uni Med Sci Health Serv 2009;31:15-20.
13. Lefevre F, Aronson N. Ketogenic diet for the treatment 
of refractory epilepsy in children: A systematic review of 
efficacy. Pediatrics 2000 Apr;105(4):105-9.
14. Keene DL. A systematic review of the use of the 
ketogenic diet in childhood epilepsy. Pediatr Neurol 2006 
Jul;35(1):1-5.
15. Porta N, Vallee L, Boutry E, Fontaine M, Dessein AF, 
Joriot S, et al. Comparsion of seizure reduction and serum 
fatty acid levels after receiving the ketogenic and modified 
Atkins diet. Seizure 2009 Jun 18(5):359-64.







Generalized tonic clonic 10% 10%
Generalized tonic 5% 35%
Myoclonic 10% 30%
Complex partial 5% 0%
Mixed 70% 25%
EEG Abnormality
Spike wave 35% 70






Focal Lesion 20% 0%
Atrophy 30% 10%
Porencephalic cyst 0% 10%
Calcification 0% 5%
Subdural effusion 0% 5%
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